118 related articles for article (PubMed ID: 23768967)
1. Glycogen synthase kinase-3β (GSK-3β) and its dysregulation in glioblastoma multiforme.
Atkins RJ; Stylli SS; Luwor RB; Kaye AH; Hovens CM
J Clin Neurosci; 2013 Sep; 20(9):1185-92. PubMed ID: 23768967
[TBL] [Abstract][Full Text] [Related]
2. Regulation of glycogen synthase kinase-3 beta (GSK-3β) by the Akt pathway in gliomas.
Atkins RJ; Dimou J; Paradiso L; Morokoff AP; Kaye AH; Drummond KJ; Hovens CM
J Clin Neurosci; 2012 Nov; 19(11):1558-63. PubMed ID: 22999562
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 inhibition in glioblastoma multiforme cells induces apoptosis, cell cycle arrest and changing biomolecular structure.
Acikgoz E; Güler G; Camlar M; Oktem G; Aktug H
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Feb; 209():150-164. PubMed ID: 30388586
[TBL] [Abstract][Full Text] [Related]
4. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
Elmaci İ; Altinoz MA
Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinases-3beta controls differentiation of malignant glioma cells.
Li Y; Lu H; Huang Y; Xiao R; Cai X; He S; Yan G
Int J Cancer; 2010 Sep; 127(6):1271-82. PubMed ID: 19882709
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
Golpich M; Amini E; Hemmati F; Ibrahim NM; Rahmani B; Mohamed Z; Raymond AA; Dargahi L; Ghasemi R; Ahmadiani A
Pharmacol Res; 2015 Jul; 97():16-26. PubMed ID: 25829335
[TBL] [Abstract][Full Text] [Related]
7. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
8. Glycogen synthase kinase 3β sustains invasion of glioblastoma via the focal adhesion kinase, Rac1, and c-Jun N-terminal kinase-mediated pathway.
Chikano Y; Domoto T; Furuta T; Sabit H; Kitano-Tamura A; Pyko IV; Takino T; Sai Y; Hayashi Y; Sato H; Miyamoto K; Nakada M; Minamoto T
Mol Cancer Ther; 2015 Feb; 14(2):564-74. PubMed ID: 25504636
[TBL] [Abstract][Full Text] [Related]
9. The role of glycogen synthase kinase-3beta in schizophrenia.
Koros E; Dorner-Ciossek C
Drug News Perspect; 2007 Sep; 20(7):437-45. PubMed ID: 17992266
[TBL] [Abstract][Full Text] [Related]
10. Tetraarsenic oxide-induced inhibition of malignant glioma cell invasion in vitro via a decrease in matrix metalloproteinase secretion and protein kinase B phosphorylation.
Gwak HS; Park MJ; Park IC; Woo SH; Jin HO; Rhee CH; Jung HW
J Neurosurg; 2014 Dec; 121(6):1483-91. PubMed ID: 25303017
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase-3beta: a prognostic marker and a potential therapeutic target in human bladder cancer.
Naito S; Bilim V; Yuuki K; Ugolkov A; Motoyama T; Nagaoka A; Kato T; Tomita Y
Clin Cancer Res; 2010 Nov; 16(21):5124-32. PubMed ID: 20889919
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase-3beta regulates astrocytic differentiation of U87-MG human glioblastoma cells.
Li Y; Lu HM; Li G; Yan GM
Acta Pharmacol Sin; 2010 Mar; 31(3):355-60. PubMed ID: 20154711
[TBL] [Abstract][Full Text] [Related]
13. Apical membrane localization of glycogen synthase kinase 3beta protein in normal colon epithelium and aberrant distribution in colorectal cancer.
Hirakawa H; Nakayama T; Shibata K; Mihara Y; Taba M; Nagayasu T; Sekine I
Cancer Lett; 2009 Mar; 275(1):158-62. PubMed ID: 19022564
[TBL] [Abstract][Full Text] [Related]
14. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways mediating phosphorylation and inactivation of glycogen synthase kinase-3β by the recombinant human δ-opioid receptor stably expressed in Chinese hamster ovary cells.
Olianas MC; Dedoni S; Onali P
Neuropharmacology; 2011 Jun; 60(7-8):1326-36. PubMed ID: 21276805
[TBL] [Abstract][Full Text] [Related]
16. Nuclear expression of glycogen synthase kinase-3β and lack of membranous β-catenin is correlated with poor survival in colon cancer.
Salim T; Sjölander A; Sand-Dejmek J
Int J Cancer; 2013 Aug; 133(4):807-15. PubMed ID: 23389968
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.
Simão F; Matté A; Pagnussat AS; Netto CA; Salbego CG
Eur J Neurosci; 2012 Oct; 36(7):2899-905. PubMed ID: 22817531
[TBL] [Abstract][Full Text] [Related]
18. Altered Wnt signalling in the teenage suicide brain: focus on glycogen synthase kinase-3β and β-catenin.
Ren X; Rizavi HS; Khan MA; Dwivedi Y; Pandey GN
Int J Neuropsychopharmacol; 2013 Jun; 16(5):945-55. PubMed ID: 23110823
[TBL] [Abstract][Full Text] [Related]
19. The Wnt pool of glycogen synthase kinase 3beta is critical for trophic-deprivation-induced neuronal death.
Hongisto V; Vainio JC; Thompson R; Courtney MJ; Coffey ET
Mol Cell Biol; 2008 Mar; 28(5):1515-27. PubMed ID: 18195042
[TBL] [Abstract][Full Text] [Related]
20. Disruption of glycogen synthase kinase-3-beta activity leads to abnormalities in physiological measures in mice.
Ahnaou A; Drinkenburg WH
Behav Brain Res; 2011 Aug; 221(1):246-52. PubMed ID: 21392539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
